US regulators urge patients to discuss with clinicians the risks of avacopan and to consider an alternative treatment to this medicine, which is approved for a rare autoimmune disease.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-issues-alert-liver-injuries-linked-vasculitis-drug-2026a10009tr?src=rss
Author :
Publish date : 2026-03-31 18:31:00
Copyright for syndicated content belongs to the linked Source.
